Latent Tuberculosis Infection: A Guide for Primary Health Care Providers

Return to Table of Contents

Resources

Websites

• Centers for Disease Control and Prevention (CDC)
  Division of Tuberculosis Elimination
  http://www.cdc.gov/tb


• TB Education and Training Resources
  http://www.findtbresources.org


• World Health Organization
  http://www.who.org

U.S. Regional Training and Medical Consultation Centers (RTMCCs)

• Francis J. Curry National Tuberculosis Center
  Website: http://www.nationaltbcenter.edu
  Phone: 415-502-4600
  Serving Alaska, California (Los Angeles, San Diego, and San Francisco), Colorado, Hawaii, Idaho, Montana, Nevada, Oregon, Utah, Washington, Wyoming, and the U.S. Affiliated Pacific Islands (USAPI).
   
• Heartland National Tuberculosis Center
  Website: http://www.heartlandntbc.org
  Phone: 1-800-839-5864
  Serving Arizona, Illinois (Chicago), Iowa, Kansas, Minnesota, Missouri, New Mexico, Nebraska, North Dakota, Oklahoma, South Dakota, Texas (Houston), and Wisconsin.
   
• New Jersey Medical School – Global Tuberculosis Institute
  Website: http://www.umdnj.edu/globaltb
  Phone: 973-972-3270
  Serving Connecticut, District of Columbia, Delaware, Indiana, Massachusetts, Maryland (Baltimore City), Maine, Michigan (Detroit), New Hampshire, New Jersey, New York (New York City), Ohio, Pennsylvania (Philadelphia), Rhode Island, Vermont, and West Virginia.
   
• Southeastern National Tuberculosis Center
  Website:http://sntc.medicine.ufl.edu
  Phone: 352-265-7682
  Serving Alabama, Arkansas, Florida, Georgia, Kentucky, Louisiana, Mississippi, North Carolina, South Carolina, Tennessee, Virginia, Puerto Rico, and the U.S. Virgin Islands.

Educational Materials for Health Care Providers*

• Mantoux Tuberculin Skin Testing Products
  (Centers for Disease Control and Prevention)
   
• Management of LTBI in Children and Adolescents
  (NJMS Global Tuberculosis Institute, 2009)
   
• Fact Sheets
  • Targeted Tuberculin Testing and Interpreting Tuberculin Skin Test Results
  • Treatment of Latent Tuberculosis Infection: Maximizing Adherence
  • Treatment Options for Latent Tuberculosis Infection
  • Interferon-Gamma Release Assay (IGRAs)
    (Centers for Disease Control and Prevention)

   

• Slide Set
  (CDC, 2005)
  • Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection: Applying CDC/ATS Guidelines in Your Clinical Practice
    (Centers for Disease Control and Prevention)

*CDC education and training materials may be viewed, downloaded, and ordered online at http://www.cdc.gov/tb.

State Health Department TB Program

Phone:
Fax:

Local Health Department TB Program

Phone:
Fax: